| 4/10/2008 | CV | Market Commentary: Endo jumps on debut; takeout news lifts Millenium, other biotechs gain; NatCity in play
|
| 12/10/2007 | CV | Market Commentary: WaMu bringing big deal; A&P watching P's & Q's; Millennium up on drug tests; MGI up on merger
|
| 11/2/2007 | CV | Market Commentary: Synaptics, Cray, Millennium up on earnings; Itron gutted; new issues open flat; Vanda doesn't open at all
|
| 8/28/2007 | CV | Market Commentary: PolyMedica convertibles skyrocket on takeover; AmeriCredit, Medtronic, slide; perfect storm slows volume
|
| 11/15/2006 | BTCV | Millennium greenshoe exercised in full, upping convertibles offer to $250 million
|
| 11/10/2006 | CV | Market Commentary: General Cable, upsized Millennium climb on trading debuts; Medis locked up; Disney slides on results
|
| 11/10/2006 | BTCV | New Issue: Millennium prices upsized $225 million five-year convertibles at 2.25%, up 37.5%
|
| 11/9/2006 | CV | Market Commentary: SanDisk higher on rumors; Amkor jumps following results; General Cable up, Millennium silent in gray
|
| 11/9/2006 | BTCV | Millennium prices upsized $225 million five-year convertibles to yield 2.25%, up 37.5%
|
| 5/17/2004 | CV | Market Commentary: Protein Design Labs plunges, Millennium set to rise on drug results; Thoratec, Tower deals emerge
|
| 4/29/2003 | CV | Millennium Pharmaceuticals says $577.8 million convertibles tendered
|
| 4/21/2003 | CV | Market Commentary: Market still in thin, holiday mode; deal flow seen picking up swiftly
|
| 4/21/2003 | CV | Cendant buys back $852 million convertibles
|
| 4/14/2003 | CV | Merrill sees Millennium offering sweetener for 4.5% and 5% converts in 8%-13.5% yield to put range
|
| 3/31/2003 | CV | Millennium may add sweetener to discourage exercise of upcoming put
|
| 7/15/2002 | CV | Market Commentary: Converts close higher despite wild swing in stock markets
|
| 5/8/2002 | CV | Moody's cuts Corning to Baa3
|
| 4/29/2002 | CV | Millennium says $40,000 out of $600 million old COR Therapeutics notes tendered
|
| 4/23/2002 | CV | Market Commentary: New issues invigorate otherwise languid market; Calpine seen heading south
|
| 4/23/2002 | CV | Deutsche analysts suggest switching out of the COR 5% into 4.5%
|
| 4/22/2002 | CV | Millennium adds put option to old COR Therapeutics convertibles
|
| 3/14/2002 | CV | Millennium starts tender COR Therapeutics convertibles, considering adding put option
|
| 12/7/2001 | CV | Market Commentary: Convertible market slides as stock enthusiasm withers, no new deals
|
| 12/6/2001 | CV | S&P rates new Photronics convertibles B
|
| 12/6/2001 | CV | Market Commentary: Convertible market slips on thwarted rally in stocks; new issues mixed
|
